[HTML][HTML] Recombinant vaccines in 2022: a perspective from the cell factory

MT de Pinho Favaro, J Atienza-Garriga… - Microbial cell …, 2022 - Springer
The last big outbreaks of Ebola fever in Africa, the thousands of avian influenza outbreaks
across Europe, Asia, North America and Africa, the emergence of monkeypox virus in …

A conversation with ChatGPT about the impact of the COVID-19 pandemic on education: Comparative review based on human–AI collaboration

T Karakose, M Demirkol, N Aslan, H Köse, R Yirci - International Journal, 2023 - ceeol.com
Background/purpose–ChatGPT, an AI-powered chatbot designed with generative pre-
trained transformer architecture, have intrigued millions of people from diverse backgrounds …

[HTML][HTML] Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial

NA Kaabi, YK Yang, J Zhang, K Xu, Y Liang… - … and Targeted Therapy, 2022 - nature.com
The increased coronavirus disease 2019 (COVID-19) breakthrough cases pose the need of
booster vaccination. We conducted a randomised, double-blinded, controlled, phase 2 trial …

[HTML][HTML] Surveillance of post-vaccination side effects of COVID-19 vaccines among Saudi population: a real-world estimation of safety profile

AI Alzarea, YH Khan, AD Alatawi, AS Alanazi… - Vaccines, 2022 - mdpi.com
Vaccines are considered to be the most beneficial means for combating the COVID-19
pandemic. Although vaccines against SARS-CoV-2 have demonstrated excellent safety …

Effectiveness and safety of COVID-19 vaccines on maternal and perinatal outcomes: a systematic review and meta-analysis

S Fernández-García, L del Campo-Albendea… - BMJ Global …, 2024 - gh.bmj.com
Objective To assess the effects of COVID-19 vaccines in women before or during pregnancy
on SARS-CoV-2 infection-related, pregnancy, offspring and reactogenicity outcomes …

[HTML][HTML] Surveillance of side effects after two doses of COVID-19 vaccines among patients with comorbid conditions: a sub-cohort analysis from Saudi Arabia

TH Mallhi, YH Khan, MH Butt, M Salman, N Tanveer… - Medicina, 2022 - mdpi.com
Background: Individuals with underlying chronic illnesses have demonstrated considerable
hesitancy towards COVID-19 vaccines. These concerns are primarily attributed to their …

COVID-19 treatments: then and now

SS Mustafa, RA Stern, PC Patel, DK Chu - The Journal of Allergy and …, 2023 - Elsevier
The coronavirus disease 2019 (COVID-19) pandemic has evolved over the past 3+ years,
and strategies to prevent illness and treat infection have changed over time. As COVID-19 …

[HTML][HTML] COVID-19 vaccination in inflammatory bowel disease (IBD)

A Kubas, E Malecka-Wojciesko - Journal of Clinical Medicine, 2022 - mdpi.com
Vaccines against SARS-CoV-2 are believed to play a key role in the suppression of the
COVID-19 pandemic. However, patients suffering from inflammatory bowel diseases (IBD) …

Assessment of intention and hesitancy to receive a booster dose of COVID-19 vaccine among community pharmacists using a vaccine hesitancy scale

A Al-taie, Z Yilmaz - Journal of Public Health, 2023 - Springer
Aim To assess the patterns regarding COVID-19 infection and vaccination, along with the
intention and hesitancy towards receiving a booster dose of the COVID-19 vaccine among …

Real-life evaluation of incidence and clinical outcomes of COVID-19 among healthcare workers during pre-vaccination and post-vaccination periods: A cross-sectional …

YE Ozdemir, AI Sezen, S Surme, S Senoglu… - The Journal of Infection …, 2023 - jidc.org
Introduction: We aimed to evaluate the prevalence and clinical outcomes of COVID-19 in
healthcare workers (HCWs) in the pre-vaccination and post-vaccination periods. In addition …